Subscribe to Newsletter

Business Practice

Discovery & Development Business Practice

In Conversation with Gary Lord of Dow Corning Healthcare at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Gary Lord from Dow Corning Healthcare

Discovery & Development Business Practice

In Conversation with Simon Edwards of Cambrex at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Simon Edwards from Cambrex

Discovery & Development Business Practice

In Conversation with Dr Jean Luc Herbeaux of Evonik at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Dr Jean Luc Herbeaux from Evonik

Manufacture Business Practice

Direct visualization, sizing and concentration measurements of drug delivery nanoparticles

In this application note, we discuss how Nanoparticle Tracking Analysis (NTA) is used to measure the size and concentration of nanoparticles used for drug delivery, such as liposomes, in order to determine efficacy and rate of uptake, degradation and clearance from the body.

Discovery & Development Business Practice

In-vitro bioequivalence studies

The Morphologi G3-ID can be used to compare the Active Pharmaceutical Ingredients (API) within oral solid dose formualtions. Here we apply it to comparing innovator and generic versions of a product containing two APIs.

Business & Regulation Business Practice

Accessing Big Pharma’s Conscience

| Jayasree K. Iyer

Sitting Down With... Jayasree K. Iyer, Executive Director, Access to Medicine Foundation

Manufacture Business Practice

Facility Innovation by Design

| Stephanie Vine

What do ISPE’s 2016 Facility of the Year Awards tell us about the future direction of the industry?

Business & Regulation Business Practice

Location, Location, Location

| James Strachan

An EMA task force prepares for the worst should the Agency's HQ be affected by Brexit.

Business & Regulation Business Practice

The Power is Close at Hand

| James Strachan

Nominations are open for the 2017 Power List, but will close in February 2017.

Business & Regulation Standards & Regulation

Safe Passage for Cures

| James Strachan

The 21st Century Cures Act is passed through US Congress – and includes big plans for the FDA.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register